Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xtremi-T was a medical technology company specializing in the development of resorbable trauma products for small bone and joint applications. Based in Lawrenceville, New Jersey, the company focused on bioabsorbable polymer technologies, such as PLLA and PLGA, to create implants that provide temporary fixation and are eventually absorbed by the body. Its lead products included the Refix Pin, which received FDA 510(k) clearance for orthopedic use in treating fractures and osteotomies. In January 2005, Xtremi-T was acquired by Small Bone Innovations (SBI) as part of a strategy to build a comprehensive portfolio of small bone and joint solutions. Following SBI's acquisition by Stryker in 2014, Xtremi-T's technologies were integrated into Stryker's orthopedic extremities division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xtremi-T.